Article info

Download PDFPDF

657 A combination treatment of bone marrow-derived CD141+dendritic cells and PD1/PD-L1 inhibitors for effective immunotherapy for solid tumors

Authors

Citation

Mun JS, Cho S, Jeon Y, et al
657 A combination treatment of bone marrow-derived CD141+dendritic cells and PD1/PD-L1 inhibitors for effective immunotherapy for solid tumors

Publication history

  • First published November 2, 2023.
Online issue publication 
November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.